Across TCGA pan-cancer cohorts, LINC02223 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LINC02223 data layer compared with 20 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LINC02223 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02223 expression acts as an unfavorable survival marker.
KIRP are the cancer types where LINC02223 Mutation most reproducibly stratifies survival.